로딩 중…
지수 로딩 중…
CorMedix Inc. Common Stock
CRMD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$8.67+0.00%
2026-06-18
Price Chart
CorMedix Inc. Common Stock-36.16%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $680M |
| Revenue | $400M |
| Net Income | $181M |
| Total Assets | $816M |
| Net Assets | $437M |
| Value | |
| P/E | 3.76x |
| P/B | 1.56x |
| PEG | 0.04x |
| P/S | 1.70x |
| EV/EBITDA | 2.93x |
| FCF Yield | 28.87% |
| Profitability | |
| ROE | 41.42% |
| ROA | 22.19% |
| Op. Margin | 48.41% |
| Revenue Growth | 226.05% |
| Earnings Growth | 86.98% |
| Financial Health | |
| Debt Ratio | 86.62% |
| Total Debt | $145M |
| FCF | $196M |
| Cash | $178M |
| Current Ratio | 2.98x |
| Net Debt/EBITDA | -0.15x |
| Performance | |
| 1Y Return | -36.16% |
| 1M Return | 10.87% |
| From 52W High | -50.26% |
| 1Y MDD | -62.26% |
| Trading | |
| Volume | 2,298,711 shares |
| Trading Value | $20M |